Effectiveness of neoadjuvant chemoradiotherapy in the treatment of rectal cancer: A comprehensive study

Eda Taş Küçük, Rahşan Habiboğlu, İlknur Kayalı

Article ID: 3534
Vol 6, Issue 1, 2023

VIEWS - 1888 (Abstract)

Abstract


This study addresses the global health challenge of rectal cancer, aiming to assess the effectiveness of neoadjuvant chemoradiotherapy and its implications for treatment outcomes in 100 retrospectively analyzed patients. The cohort underwent neoadjuvant chemoradiotherapy followed by sphincter-sparing surgery, with recorded parameters including demographics, tumor stage, treatment protocol, and surgical outcomes. Results indicated tumor reduction in 80% of patients, with a 15% complication rate for sphincter-sparing surgery. Pathological examination underscored neoadjuvant treatment’s impact on tumor regression and reduced lymph node metastasis. In conclusion, the study emphasizes the demonstrated efficacy of neoadjuvant chemoradiotherapy in rectal cancer treatment, advocating for a comprehensive approach to managing this condition.

Keywords


neoadjuvant chemoradiotherapy; rectal cancer; treatment outcomes; effectiveness

Full Text:

PDF


References


Morgan E, Arnold M, Gini A, et al. Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN. Gut 2022; 72(2): 338–344. doi: 10.1136/gutjnl-2022-327736 Gunderson LL, Jessup JM, Sargent DJ, et al. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. Journal of Clinical Oncology 2010; 28(2): 256–263. doi: 10.1200/jco.2009.23.9194 Benson AB, Venook AP, Al-Hawary MM, et al. Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network 2018; 16(7): 874–901. doi: 10.6004/jnccn.2018.0061 Rödel C, Liersch T, Becker H, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: Initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. The Lancet Oncology 2012; 13(7): 679–687. doi: 10.1016/s1470-2045(12)70187-0 Cisel B, Pietrzak L, Michalski W, Wyrwicz L, et al. Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: Long-term results of the randomized Polish II study. Ann Oncol 2019; 30(8): 1298–303. doi: 10.1093/annonc/mdz180 Bahadoer RR, Dijkstra EA, van Etten B, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): A randomised, open-label, phase 3 trial. Lancet Oncol 2021; 22(1): 29–42. doi: 10.1016/S1470-2045(20)30599-5 Yuki S, Bando H, Tsukada Y, et al. SO-37 Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stability and microsatellite instability-high, locally advanced rectal cancer (EPOC 1504). Annals of Oncology 2020; 31: S230–S231. doi: 10.1016/j.annonc.2020.04.052 Lin Z, Cai M, Zhang P, et al. Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer. Journal for ImmunoTherapy of Cancer 2021; 9(11): e003554. doi: 10.1136/jitc-2021-003554 Gérard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. Journal of Clinical Oncology 2006; 24(28): 4620–4625. doi: 10.1200/jco.2006.06.7629 Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results—EORTC 22921. Journal of Clinical Oncology 2005; 23(24): 5620–5627. doi: 10.1200/jco.2005.02.113 Bai X, Li S, Yu B, et al. Sphincter-preserving surgery after preoperative radiochemotherapy for T3 low rectal cancers. Oncology Letters 2012; 3(6): 1336–1340. doi: 10.3892/ol.2012.574 Brændengen M, Tveit KM, Berglund Å, et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. Journal of Clinical Oncology 2008; 26(22): 3687–3694. doi: 10.1200/jco.2007.15.3858 Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. New England Journal of Medicine 2004; 351(17): 1731–1740. doi: 10.1056/nejmoa040694 Barbaro B, Fiorucci C, Tebala C, et al. Locally advanced rectal cancer. MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 2009; 250: 730–739. doi: 10.1148/radiol.250308042 Calvo FA, Domper M, Matute R, et al. 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. International Journal of Radiation Oncology Biology Physics 2004; 58(2): 528–535. doi: 10.1016/j.ijrobp.2003.09.058 Roh MS, Colangelo LH, O’Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. Journal of Clinical Oncology 2009; 27(31): 5124–5130. doi: 10.1200/jco.2009.22.0467 Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemoradiotherapy. Radiotherapy and Oncology 2004; 72(1): 15–24. doi: 10.1016/j.radonc.2004.01.010 Bosset JF, Arbez-Gindre F, Pelissier E, et al. Anatomo-pathological factors in the prognosis of rectal cancers. A mono- and multifactorial study. Gastroentérologie Clinique Et Biologique 1986; 10(11): 728–735. Minsky BD, Mies C, Rich TA, et al. Potentially curative surgery of colon cancer: The influence of blood vessel invasion. Journal of Clinical Oncology 1988; 6(1): 119–127. doi: 10.1200/jco.1988.6.1.119 Ouchi K, Sugawara T, Ono H, et al. Histologic features and clinical significance of venous invasion in colorectal carcinoma with hepatic metastasis. Cancer 1996; 78(11): 2313–2317. doi: 10.1002/(sici)1097-0142(19961201)78: 11<2313: : aid-cncr7>3.0.co, 2-n Krasna MJ, Flancbaum L, Cody RP, et al. Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer 1988; 61(5): 1018–1023. doi: 10.1002/1097-0142(19880301)61: 5<1018: : aid-cncr2820610527>3.0.co, 2-h



DOI: https://doi.org/10.24294/irr.v6i1.3534

Refbacks

  • There are currently no refbacks.


License URL: https://creativecommons.org/licenses/by-nc/4.0/

This site is licensed under a Creative Commons Attribution 4.0 International License.